TLR9 and colitis: Furthermore, it has been observed in a CD4+ T-cell-dependent Severe combined immunodeficiency (SCID) transfer model of colitis that pretreatment of donor mice with CpG completely abolished colitis development in SCID recipients in a CpG–TLR9-mediated modulation of T-cell function (85).